You'll receive a response shortly. The verdict: With its highly intoxicating twin-turbocharged V-8, the 2024 BMW X5 M60i blurs the line between simply being an X5 with an uplevel engine and a full ...

The 2023 BMW X5 xDrive45e has proven itself one of the top plug-in hybrid choices in the luxury SUV space based on our instrumented testing and time behind the wheel. Its turbocharged inline-six ...

Fuel-efficient plug-in hybrid powertrains are taking hold, popping up in every type of vehicle including mid-size luxury SUVs such as the 2021 BMW X5 xDrive45e. Here, a turbocharged inline-six and ...

The new X5 will feature Neue Klasse-inspired design but won’t use the new platform. Maintaining several ICE versions will be important to ensure its success in the market. The electric iX5 will ...

Your browser does not support the audio element. The electric BMW iX5 is set for an international launch in 2026, alongside the fifth-generation X5 with upgraded ...

Fluid and coating equipment company Graco (NYSE:GGG) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 3.2% year on year to $548.7 million. Its non-GAAP profit of $0.64 ...

MINNEAPOLIS, January 27, 2025--(BUSINESS WIRE)--Graco Inc. (NYSE: GGG) today announced results for the fourth quarter ended December 27, 2024. $ in millions except per share amounts ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

The Reebok Nano X5 is like a footballer finally finding their feet at a new club. Reebok has built a spacious, well-rounded “little bit of everything” cross training shoe that steers away from ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...